PSI Continues Growth in North America

ZUG, Switzerland--()--PSI CRO, a full service Contract Research Organization, known for predictable, on-time enrollment and project delivery, announced today that it has continued to expand the staffing and service offerings in North America.

In response to the increasing needs of its clients for global clinical trials, PSI moves forward with continued growth in North America with services and staffing. PSI’s Philadelphia office location is home for the support services for North America that include Clinical Operations, Data Management, Medical Affairs, Medical Writing, Feasibility, Legal, Vendor Management and others. The portfolio of PSI North American services has recently been expanded to include IND submissions. The PSI offices in San Francisco support all of Project Management.

PSI’s growth in North America will continue to be organic and well-paced. We are putting effort into careful selection and training of staff who share PSI’s values and passion for on-time delivery.

PSI is actively working in areas of Oncology, Oncohematology, Hemophilia, Infectious Diseases, Multiple Sclerosis, Nephrology, Endocrinology, Autoimmune, Rare Diseases, Gastroenterology, Cardiology and others.

PSI is particularly strong in pediatrics having successfully managed largest industry sponsored pediatric programs resulting in drug approvals.

About PSI CRO AG: PSI is a privately-held, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries and continents. PSI is known to be highly selective about the work that they pursue. PSI has exceptionally high repeat and referral business rates, while maintaining minimal staff turnover indicative of its commitment to be the best CRO in the world as measured by its customers and its employees. Global headquarters are located in Zug (Zürich), Switzerland at 113a Baarerstrasse 6300. www.psi-cro.com

Contacts

PSI CRO AG
Barbara Breen, +1 847-202-1120
Marketing@psi-cro.com

Release Summary

PSI CRO continues to expand its staffing and service offerings in North America in response to the increasing needs of its clients for global clinical trials.

Contacts

PSI CRO AG
Barbara Breen, +1 847-202-1120
Marketing@psi-cro.com